For example, GPX4, as a negative regulator of iron apoptosis, plays a major antioxidant role in anti-cancer activity and the inhibition of GPX4 can enhance ferroptosis and thus enhance the sensitivity of CRC to cisplatin/oxaliplatin [49,282]. The gene discussed is GPX4; the disease is cancer.